Sumatriptan Succinate Market Status and Trend Analysis 2017-2026 (COVID-19 Version)

1 RESEARCH SCOPE

1.1 Research Product Definition

1.2 Research Segmentation

1.2.1 Product Type

1.2.2 Main product Type of Major Players

1.3 Demand Overview

1.4 Research Methodology

2 GLOBAL SUMATRIPTAN SUCCINATE INDUSTRY

2.1 Summary about Sumatriptan Succinate Industry

2.2 Sumatriptan Succinate Market Trends

2.2.1 Sumatriptan Succinate Production & Consumption Trends

2.2.2 Sumatriptan Succinate Demand Structure Trends

2.3 Sumatriptan Succinate Cost & Price

3 MARKET DYNAMICS

3.1 Manufacturing & Purchasing Behavior in 2020

3.2 Market Development under the Impact of COVID-19

3.2.1 Drivers

3.2.2 Restraints

3.2.3 Opportunity

3.2.4 Risk

4 GLOBAL MARKET SEGMENTATION

4.1 Region Segmentation (2017 to 2021f)

4.1.1 North America (U.S., Canada and Mexico)

4.1.2 Europe (Germany, UK, France, Italy, Rest of Europe)

4.1.3 Asia-Pacific (China, India, Japan, South Korea, Southeast Asia, Australia, Rest of Asia Pacific)

4.1.4 South America (Brazil,, Argentina, Rest of Latin America)

4.1.5 Middle East and Africa (GCC, North Africa, South Africa, Rest of Middle East and Africa)

4.2 Product Type Segmentation (2017 to 2021f)

4.2.1 Tablet 

4.2.2 Subcutaneous Injection 

4.2.3 Nasal Spray

4.3 Consumption Segmentation (2017 to 2021f)

4.3.1 Oral 

4.3.2 Subcutaneous Injection

5 NORTH AMERICA MARKET SEGMENT

5.1 Region Segmentation (2017 to 2021f)

5.1.1 U.S.

5.1.2 Canada

5.1.3 Mexico

5.2 Product Type Segmentation (2017 to 2021f)

5.2.1 Tablet 

5.2.2 Subcutaneous Injection 

5.2.3 Nasal Spray

5.3 Consumption Segmentation (2017 to 2021f)

5.3.1 Oral 

5.3.2 Subcutaneous Injection

5.4 Impact of COVID-19 in North America

6 EUROPE MARKET SEGMENTATION

6.1 Region Segmentation (2017 to 2021f)

6.1.1 Germany

6.1.2 UK

6.1.3 France

6.1.4 Italy

6.1.5 Rest of Europe

6.2 Product Type Segmentation (2017 to 2021f)

6.2.1 Tablet 

6.2.2 Subcutaneous Injection 

6.2.3 Nasal Spray

6.3 Consumption Segmentation (2017 to 2021f)

6.3.1 Oral 

6.3.2 Subcutaneous Injection

6.4 Impact of COVID-19 in Europe

7 ASIA-PACIFIC MARKET SEGMENTATION

7.1 Region Segmentation (2017 to 2021f)

7.1.1 China

7.1.2 India

7.1.3 Japan

7.1.4 South Korea

7.1.5 Southeast Asia

7.1.6 Australia

7.1.7 Rest of Asia Pacific

7.2 Product Type Segmentation (2017 to 2021f)

7.2.1 Tablet 

7.2.2 Subcutaneous Injection 

7.2.3 Nasal Spray

7.3 Consumption Segmentation (2017 to 2021f)

7.3.1 Oral 

7.3.2 Subcutaneous Injection

7.4 Impact of COVID-19 in Europe

8 SOUTH AMERICA MARKET SEGMENTATION

8.1 Region Segmentation (2017 to 2021f)

8.1.1 Brazil

8.1.2 Argentina

8.1.3 Rest of Latin America

8.2 Product Type Segmentation (2017 to 2021f)

8.2.1 Tablet 

8.2.2 Subcutaneous Injection 

8.2.3 Nasal Spray

8.3 Consumption Segmentation (2017 to 2021f)

8.3.1 Oral 

8.3.2 Subcutaneous Injection

8.4 Impact of COVID-19 in Europe

9 MIDDLE EAST AND AFRICA MARKET SEGMENTATION

9.1 Region Segmentation (2017 to 2021f)

9.1.1 GCC

9.1.2 North Africa

9.1.3 South Africa

9.1.4 Rest of Middle East and Africa

9.2 Product Type Segmentation (2017 to 2021f)

9.2.1 Tablet 

9.2.2 Subcutaneous Injection 

9.2.3 Nasal Spray

9.3 Consumption Segmentation (2017 to 2021f)

9.3.1 Oral 

9.3.2 Subcutaneous Injection

9.4 Impact of COVID-19 in Europe

10 COMPETITION OF MAJOR PLAYERS

10.1 Brief Introduction of Major Players

10.1.1 GlaxoSmithKline 

10.1.2 Imitrex 

10.1.3 Teva 

10.1.4 Sandoz 

10.1.5 Mylan 

10.1.6 Roxane Pa 

10.1.7 Dabur Pharmaceuticals 

10.1.8 Sun Pharmaceutical

10.2 Sumatriptan Succinate Sales Date of Major Players (2017-2020e)

10.2.1 GlaxoSmithKline 

10.2.2 Imitrex 

10.2.3 Teva 

10.2.4 Sandoz 

10.2.5 Mylan 

10.2.6 Roxane Pa 

10.2.7 Dabur Pharmaceuticals 

10.2.8 Sun Pharmaceutical

10.3 Market Distribution of Major Players

10.4 Global Competition Segmentation

11 MARKET FORECAST

11.1 Forecast by Region

11.2 Forecast by Demand

11.3 Environment Forecast

11.3.1 Impact of COVID-19

11.3.2 Geopolitics Overview

11.3.3 Economic Overview of Major Countries

12 REPORT SUMMARY STATEMENT

Table Sumatriptan Succinate Product Type Overview

Table Sumatriptan Succinate Product Type Market Share List

Table Sumatriptan Succinate Product Type of Major Players

Table Brief Introduction of GlaxoSmithKline 

Table Brief Introduction of Imitrex 

Table Brief Introduction of Teva 

Table Brief Introduction of Sandoz 

Table Brief Introduction of Mylan 

Table Brief Introduction of Roxane Pa 

Table Brief Introduction of Dabur Pharmaceuticals 

Table Brief Introduction of Sun Pharmaceutical

Table Products & Services of GlaxoSmithKline 

Table Products & Services of Imitrex 

Table Products & Services of Teva 

Table Products & Services of Sandoz 

Table Products & Services of Mylan 

Table Products & Services of Roxane Pa 

Table Products & Services of Dabur Pharmaceuticals 

Table Products & Services of Sun Pharmaceutical

Table Market Distribution of Major Players

Table Global Major Players Sales Revenue (Million USD) 2017-2020e

Table Global Major Players Sales Revenue (Million USD) Share 2017-2020e

Table Global Sumatriptan Succinate Market Forecast (Million USD) by Region 2021f-2026f

Table Global Sumatriptan Succinate Market Forecast (Million USD) Share by Region 2021f-2026f

Table Global Sumatriptan Succinate Market Forecast (Million USD) by Demand 2021f-2026f

Table Global Sumatriptan Succinate Market Forecast (Million USD) Share by Demand 2021f-2026f